Skip to content
The future of next-generation obesity drugs
The metabolic field is the hottest biotech therapeutic area of the year (and likely to continue beyond). In the context of a difficult couple […]
The future of next-generation obesity drugs Read More »
What policy biotech should be watching this election year
The biotech industry must constantly navigate the ins and outs of Beltway politics. During an election year, the need to anticipate and plan for
What policy biotech should be watching this election year Read More »
CEOs explore challenges and opportunities in vaccine pipeline
The Biotechnology Innovations Organization (BIO) report, The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases, on January 25, 2024, found that
CEOs explore challenges and opportunities in vaccine pipeline Read More »
How biomarkers can support regulatory rare disease pathways
On February 21, the Biotechnology Innovation Organization’s (BIO) soon-to-be President & CEO, John F. Crowley, joined an event about biomarkers and rare disease regulatory
How biomarkers can support regulatory rare disease pathways Read More »
AstraZeneca announces new $300 million Maryland facility
AstraZeneca recently announced that it is investing $300 million in a Rockville, MD facility “to launch its life-saving cell therapy platforms in the US
AstraZeneca announces new $300 million Maryland facility Read More »
GSK survey shows optimism for the future of biotech innovation
GSK believes that “innovation starts when we stop to listen.” In 2023, GSK took a moment to engage with a variety of people across
GSK survey shows optimism for the future of biotech innovation Read More »
BIO comments on NIST proposal to use march-in rights for price controls
Contention over the Bayh-Dole march-in rights provision is in the news again. The National Institute of Standards and Technology (NIST) proposes using the process
BIO comments on NIST proposal to use march-in rights for price controls Read More »
Legislation on PBM reform, preventive care advances in House
Tuesday, Feb. 6 was a busy day on Capitol Hill for health legislation. Two bills advanced through committees. The House Oversight & Investigations Committee
Legislation on PBM reform, preventive care advances in House Read More »
EPIC Act would fix IRA’s ‘pill penalty’ for small molecule drugs
A bipartisan amendment to the Inflation Reduction Act (IRA), introduced in the House on January 31, would fix the law’s small molecule “pill penalty”
EPIC Act would fix IRA’s ‘pill penalty’ for small molecule drugs Read More »
New Scottish study adds to HPV vaccine confidence
As Cervical Cancer Awareness Month wraps up, there is some great news on the HPV vaccine front coming out of Scotland. Published in
New Scottish study adds to HPV vaccine confidence Read More »